Site Map Press Room Careers
Business Strategy
Organizational Strengths
R & D Focus
Custom Synthesis
Customer Testimonials
CRAMS Division
Research & Development

The Company's R & D strengths are in developing intellectual property in the area of non-infringing processes and resolving complex chemistry challenges. In the process, Aurobindo Pharma is developing new drug delivery systems, new dosage formulations, applying new technology for better processes.

The APL Research Center, two in Hyderabad covers over 13000 sq meter, and provides a nurturing environment to a multi-disciplinary team of over 700 scientists striving for excellence.

The Centre meets cGLP requirements, and is focused on the areas of organic synthesis, analytical research, dosage form development, pharmacology, bio-equivalence studies and drug delivery systems.
The instrumentation and analytical knowledge base at the Centre facilitate,
Process development life cycles of less than three months, even if it involves complex multi step synthesis with multiple chirality.
Complete impurity profiling in all products developed.
Development of analytical methods and specifications from raw materials, to non-compendia finished products.
In-house synthesis of reagents for analyzing organo lithiums and noble metals.
Accelerated and real-time stability studies.
This reflects the Company’s commitment towards developing innovative technologies and creating a knowledge base in chemical synthesis, high quality generic formulation and development of drug delivery systems.
Aurobindo will be good formulation company with the largest Active Pharmaceutical Ingredients manufacturer under CGMP qualified plant.

Director, Hanmi Pharm Co., Ltd, Korea
Site Map Press Room Careers